Skip to main content

beclometasone dipropionate (Beclu®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name beclometasone dipropionate (Beclu®)
Formulation inhalation solution
Reference number 5294
Indication

For the prophylactic management of mild, moderate, or severe asthma in adults or children: Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis. Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone. Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms

Company Lupin Healthcare (UK) Ltd
BNF chapter Respiratory system
Assessment type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 04/07/2023
Follow AWTTC: